BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14996365)

  • 1. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
    Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
    Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
    Massamba L; Madamet M; Benoit N; Chevalier A; Fonta I; Mondain V; Jeandel PY; Amalvict R; Delaunay P; Mosnier J; Marty P; Pomares C; Pradines B
    Malar J; 2020 Jan; 19(1):37. PubMed ID: 31964401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
    Khositnithikul R; Tan-Ariya P; Mungthin M
    Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.
    Mkulama MA; Chishimba S; Sikalima J; Rouse P; Thuma PE; Mharakurwa S
    Malar J; 2008 May; 7():87. PubMed ID: 18495008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
    Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
    Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
    J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
    Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
    Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
    Cortese JF; Plowe CV
    Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
    Wichmann O; Muehlen M; Gruss H; Mockenhaupt FP; Suttorp N; Jelinek T
    Malar J; 2004 Jun; 3():14. PubMed ID: 15186499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP; Teun Bousema J; Eggelte TA; Schreiber J; Ehrhardt S; Wassilew N; Otchwemah RN; Sauerwein RW; Bienzle U
    Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea.
    Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF
    Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R; Basco LK
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
    Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
    Canfield CJ; Milhous WK; Ager AL; Rossan RN; Sweeney TR; Lewis NJ; Jacobus DP
    Am J Trop Med Hyg; 1993 Jul; 49(1):121-6. PubMed ID: 8352384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.
    Fivelman QL; Butcher GA; Adagu IS; Warhurst DC; Pasvol G
    Malar J; 2002 Feb; 1():1. PubMed ID: 12057021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
    Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
    Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.